Literature DB >> 9477535

The percentage of feline, canine, avian and exotic animal consultations in veterinary practice in The Netherlands in 1994 and suggested consequences for the veterinary curriculum and residency programs.

J T Lumeij1, N Endenburg, B R Luyten.   

Abstract

The percentage of feline, canine, avian and exotic animal consultations in 1994 was established by means of a survey among veterinary practitioners in the Netherlands. The results from the response to a questionnaire which was sent to companion animal practitioners were compared with those of an at random telephone survey and tested for reliability. Results showed that the cat tended to be the most frequently presented species in companion animal practice in the Netherlands in 1994 (46%), followed by dogs (44%) and birds and exotic animals (10%). In mixed practices these percentages were 40%, 51%, and 9% respectively. From the 'avian and exotic animal' group the following species or orders were the most important: rabbits (32%), rodents (26%), parrots (12%), pigeons (9%), songbirds (9%), ferrets (4%), others (8%). It is concluded that the veterinary curriculum should be adapted to prepare veterinary students to deal with this greater variety in pet animals species and related problems. The need to include exotic animal medicine in resident training programmes is emphasized.

Entities:  

Mesh:

Year:  1998        PMID: 9477535     DOI: 10.1080/01652176.1998.9694834

Source DB:  PubMed          Journal:  Vet Q        ISSN: 0165-2176            Impact factor:   3.320


  2 in total

1.  Survey of the UK veterinary profession: common species and conditions nominated by veterinarians in practice.

Authors:  T D Nielsen; R S Dean; N J Robinson; A Massey; M L Brennan
Journal:  Vet Rec       Date:  2014-02-25       Impact factor: 2.695

2.  Confidence of veterinary surgeons in the United Kingdom in treating and diagnosing exotic pet species.

Authors:  Alison Wills; Susan Holt
Journal:  Vet Rec       Date:  2020-02-03       Impact factor: 2.695

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.